Mogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems, 2020). The platforms, MOGRIFY® and epiMOGRIFY®, developed over a 12-year period via a multi-national research collaboration, deploy next-generation sequencing, … Continued

Milltons brings together patients and researchers in order to find new therapeutic approaches to painful yet neglected chronic illnesses. We are building an ever-growing community of patients, researchers, medical associations and universities actively involved in large-scale Pan-European studies. Together, we are devising new therapeutic mechanisms to ease the pain and stop deterioration of the illnesses.  … Continued

MicrosensDx is a dynamic and ambitious innovator at the leading edge of the diagnostics sector for more than 20 years. MicrosensDX is building a global brand, delivering sample to result molecular solutions, transforming patient outcomes with fast accurate diagnosis. Our vision is to build a global brand delivering innovative diagnostic solutions which transform patient outcomes. … Continued

Johnson Matthey’s vision is for a world that’s cleaner and healthier, today and future generations.  ​ We are leaders in sustainable technologies and we apply our science to solve our customer’s most complex problems. We work with customers and partners across markets from pharmaceutical and medical to automotive, industrial and chemical production.

Finding faster and smarter ways to discover new and better drugs by actively applying AI to precision engineer medicines more rapidly and efficiently.

Dr. Reddy’s Laboratories Ltd. is an integrated global pharmaceutical company with a commercial presence in more than 20 countries, and wholly-owned subsidiaries in US, UK, Russia, Germany and Brazil and joint ventures in China, South Africa and Australia.  Dr. Reddy’s has over 20,000 employees working across the globe and a network of 25 manufacturing facilities … Continued

‘We are building a new method for instrument free single cell analysis’ Our transformative new technology for single cell genomics replaces complex hardware and manual time-consuming workflows with a simple, instrument-free, solution-based, kinetic confinement assay that plugs seamlessly into any molecular biology laboratory.

CN Bio is a leading bioengineering company specialising in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of tomorrow’s medicines. Consumer goods, chemical companies and regulators use our microphysiological (MPS) systems and consumables to analyze novel compounds, assessing toxicity … Continued

Cerevance is a new pharmaceutical company focused on central nervous system diseases. Our strengths include a powerful technology platform, a pipeline of novel discovery-stage and clinical-stage compounds and a proven team. We believe that we are well positioned to deliver life-changing therapeutics for patients who have brain-related disorders while creating value for our employees and … Continued

Science for a Better Life. As an innovative and research-based company, Bayer CropScience is committed to providing efficient and tailor-made solutions for its customers in the UK agricultural, garden and amenity markets. Committed to open communication, Bayer CropScience is setting the standard in areas of product and environmental stewardship.